Exclusive mutations related to isoniazid and ethionamide resistance among Mycobacterium tuberculosis isolates from Korea

International Journal of Tuberculosis and Lung Disease

Volumn 4, Issue 5, 2000, Pages 441-447

  Lee, H ^a   Cho, Sang Nae ^a   Bang, H E ^a   Lee, J H ^a   Bai, G H ^a   Kim, S J ^a   Kim, J D ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

inhA; Isoniazid (INH) and ethionamide (ETH) resistance; M. tuberculosis; Sequence polymorphism

Indexed keywords

CYCLOSERINE; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; KANAMYCIN; OFLOXACIN; RIFAMPICIN; STREPTOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL MUTATION; CONTROLLED STUDY; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STRAIN DIFFERENCE;

ANTITUBERCULAR AGENTS; BASE SEQUENCE; DRUG RESISTANCE, MULTIPLE; ETHIONAMIDE; HUMANS; ISONIAZID; KOREA; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MUTATION; MYCOBACTERIUM TUBERCULOSIS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; SEQUENCE ANALYSIS, DNA; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 0034023994     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Frieden T R, Sterling T, Pablos-Mendez A, Kilburn J O, Cauthen G M, Dooley S W. The emergence of drug-resistant tuberculosis in New York City. N Engl J Med 1993; 328: 521-526.
2. Iseman M. Treatment of multidrug-resistant tuberculosis. N Engl J Med 1993; 329: 784-791.
3. Kim S J, Hong Y P. Drug resistance of Mycobacterium tuberculosis in Korea. Tubercle Lung Dis 1992; 73: 219-224.
4. Musser J M. Antimicrobial agent resistance in mycobacteria: molecular genetic insights. Clin Microb Rev 1995; 8: 496-514.
5. Snider D E Jr, Roper W L. The new tuberculosis. N Engl J Med 1992; 326: 703-705.
6. Felmlee T A, Liu Q, Whelen A C, Williams D, Sommer S, Persing D H. Genotypic detection of Mycobacterium tuberculosis rifampin resistance: comparison of single-strand conformation polymorphism and dideoxy fingerprinting. J Clin Microbiol 1995; 33: 1617-1623.
7. Jacobs W R Jr, Barletta R G, Udani R, et al. Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages. Science 1993; 260: 819-822.
8. Musser J M, Kapur V, Williams D L, Kreiswirth B N, van Soolingen D, van Embden J D A. Characterization of the catalase-peroxidase gene (katG) and inhA locus in isoniazid-resistant and -susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: restricted array of mutations associated with drug resistance. J Infect Dis 1996; 173: 196-202.
9. Orita M, Iwahana H, Kanazawa H. Hayashi K, Sekiya T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 1989; 86: 2766-2770.
10. Orita M, Suzuki Y, Sekiya T, Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 1989; 5: 875-879.
11. Snider D E Jr, Good R C, Kilburn J O Jr, et al. Rapid drug-susceptibility testing of Mycobacterium tuberculosis. Am Rev Respir Dis 1981; 123: 402-406.
12. Whelen A C, Felmlee T A, Hunt J M, et al. Direct genotypic detection of Mycobacterium tuberculosis rifampin resistance in linical specimens by using single-tube heminested PCR. J Clin Microbiol 1995; 33: 556-561.
13. Davidson L A, Takayama K. Isoniazid inhibition of the synthesis of mono-unsaturated long-chain fatty acid in Mycobacterium tuberculosis H37Ra. Antimicrob Agents Chemother 1979; 16: 104-105.
14. Takayama K, Wang L, David H L. Effect of isoniazid on the in vivo mycolic acid synthesis, cell growth, and viability of Mycobacterium tuberculosis. Antimicrob Agents Chemother 1972; 2: 29-35.
15. Takayama K, Schnoes H K, Armstrong E L, Boyle R W. Site of inhibitory action of isoniazid in the synthesis of mycolic acids in Mycobacterium tuberculosis. J Eipid Res 1975; 16: 308-317.
16. Banerjee A, Dubnau E, Quemard A, Balasubramanian V, et al. inhA. a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 1994; 263: 227-230.
17. Heym B, Honore N, Truffot-Pernot C, et al. Implication of multidrug resistance for the future of short-course chemotherapy of tuberculosis; a molecular study. Lancet 1994; 344: 293-298.
18. Kapur V, Li L L, Hamrick M R. et al. Rapid Mycobacterium species assignment and unambiguous identification of mutations associated with antimicrobial resistance in Mycobacterium tuberculosis by automated DNA sequencing. Arch Pathol Lab Med 1995; 119: 131-138.
19. Midluli K, Slayden R A, Zhu Y, et al. Inhibition of a Mycobacterium tuberculosis beta-ketoacyl ACP synthase by isoniazid. Science 1998; 280: 1607-1610.
20. Kubika G P, Hones W D Jr, Abbott V D, et al. Differential identification of mycobacteria. I. Tests on catalase activity. Am Rev Respir Dis 1966; 94: 400-405.
21. Gutierrez M, Samper S, Gavigan J-A, Marin J F G, Martin C. Differentiation by molecular typing of Mycobacterium bovis strains causing tuberculosis in cattle and goats. J Clin Microbiol 1995; 33: 2953-2956.
22. Ristow M. Mohlig M, Rifai M, Schatz H, Feldman K, Pfeiffer A. New isoniazid ethionamide resistance gene mutation and screening for multidrug-resistant Mycobacterium tuberculosis strains. Lancet 1995; 346: 502-503.
23. Ross B C, Dwyer B. Rapid, simple method for typing isolates of Mycobacterium tuberculosis by using the polymerase chain reaction. J Clin Microbiol 1993; 31: 329-334,
24. Sanger F, Nicklen S, Coulson A R. Nurleotide sequencing with chain-termination inhibitors. Proc Natl Sci USA 1977; 74: 5463-5467.
25. Zhang Y, Heym B, Allen B, Young D, Cole S T. The catalase peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature 1992; 358: 501-593.
26. Rinder H, Thomaschke A, Rusch-Gerdes S, et al. Significance of ahpC promoter mutations for the prediction of isoniazid resistance in Mycobacterium tuberculosis. Eur J Clin Microbiol Infect Dis 1998; 17: 508-511.
27. Johnsson K, King D S. Schultz P G. Studies on the mechanism of action of isoniazid and ethionamide in the chemotherapy of tuberculosis. J Am Chem Soc 1993; 117: 5009-5010.
28. Quemard A, Dessen A, Sugantino M, Jacobs W R Jr, Sacchettini J C, Blanchard J S. Binding of catalase-peroxidase-activated isoniazid to wild-type and mutant Mycobacterium tuberculosis enoyl-ACP reductases. J Am Chem Soc 1996; 118: 1561-1562.
29. Mdluli K, Sherman D R, Mickey M J, et al. Biochemical and genetic data suggest that InhA is not the primary target for acti-vated isoniazid in Mycobacterium tuberculosis. J Infect Dis 1996; 174: 1085-1090.